CTORNasdaqPharmaceutical Preparations

Citius Oncology, Inc. (CTOR) earnings date, market-implied expected move, and options open interest by expiry

0.54

−0.02 · −2.73%

Regular session12:31 ET

Open0.58Volume378,809Mkt cap$64.1MEPS-0.47

Day0.54 – 0.580%52-wk0.49 – 1.833%

CTOR

Citius Oncology, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Feb 12

before open · in 100 days

est.Q1 FY27

Calendar

Next report

Last report

+2.57%

shaded = implied · ▲▼ = realized

Oct 26 '26 · confirmed

Implied vs realized

Linked news

6hRDY · supplierDR Reddys allots 5,91,270 equity shares on exercise of employee stock options

News

Largest filed tie

13F top-10 QoQ

−1.36%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

Top fund weight

0.00%

CTOR weight · VTI

N-PORTJun 30 '26

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Citius Oncology (CTOR) is expected to report on Feb 12 before open (estimated date).

Implied vs realized

2 reports

—≥ implied

Q3 FY26Aug 14 '26confirmed—▼−18.66%—

Oct 26 '26Oct 26 '26confirmed—▲+2.57%—

quarterimplied−20%0+20%realized×

Oct '26—▲+2.57%—

Q3 FY26—▼−18.66%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

No open-interest data.

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ3 FY26

−597.40%as filednet margin · revenue −10.41% QoQ

Revenue$1M−10.41%

Gross profit$1M67.07%−25.14%

Operating income−$9M−583.54%+69.54%

Pre-tax income−$9M+66.35%

Net income−$9M−597.40%+66.46%

Cost of revenue$491,843+49.55%

Operating expenses$10M−67.55%

Tax−$107,347+53.57%

Other expense−$314,376−117.73%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 12:30 ET

Intraday

Event sensitivity

PPI ×1.18· ±5.4% vs ±4.6% · 10 releases

eventrelease day|move|up · n×base

PPIproducer prices±5.4%7 of 10×1.18

PCEpersonal income & outlays±5.3%9 of 19×1.15

GDPgross domestic product±4.9%10 of 19×1.07

CPROFcorporate profits±4.8%6 of 12×1.06

FOMCrate decision±4.3%7 of 20×0.93

CPIconsumer prices±4.1%5 of 10×0.89

NFPjobs report±2.9%3 of 10×0.63

Bar = avg |move| to ±6% · tick = ±4.6% avg day · ×base = |move| ÷ ±4.6% · min 6 releases

Earnings history

EPS -0.08 · consensus —

Quarter	Reported	EPS	Consensus
Q3 FY26	Aug 14 '26 · confirmed	-0.08	—
Q2 FY26	—	-0.27	—
Q1 FY26	—	-0.06	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod